tykhr
sign in
free sign up
VistaGen Therapeutics Inc
Biotechnology
Healthcare
VTGN
28.86 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
3.40
52 week high
3.69
high
3.53
52 week low
0.00
low
3.33
growth
9.21 %
previous Close
3.33
P/E ratio
market cap
58.32 M
div yield
0
usd
Mar 2025
qoq
revenue
-15.00 K
-106.41 %
net incoming
-13.64 M
3.22 %
eps
0.00 %
4.35 %
eps surprise
48.24 %
net profit margin
90900.00 %
96920.00 %
operating incoming
-14.50 M
4.13 %
net change in cash
-7.58 M
20.43 %
cash on hand
67.13 M
-10.15 %
cost of revenue
161 K
0.00 %
top